Acadia Pharmaceuticals Partners with KYORIN Pharmaceutical for DAYBUE STIX Distribution in Japan
Trendline US

Acadia Pharmaceuticals Partners with KYORIN Pharmaceutical for DAYBUE STIX Distribution in Japan

What's Happening? Acadia Pharmaceuticals Inc. has entered into an exclusive distribution agreement with KYORIN Pharmaceutical Co., Ltd. for the commercialization of DAYBUE STIX (trofinetide) in Japan. This agreement focuses on the treatment of Rett syndrome, a rare neurological disorder. Under the t
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.